This website uses cookies to enhance the user experience.
LYFSTONE AS

LYFSTONE AS980 675 092

Research
Limited company
Sykehusvegen 21 9019 TROMSØ, Norge

LYFSTONE AS

Homepage - Lyfstone
Lyfstone Calprotectin POC test uses synovial fluid to detect periprosthetic joint infection early and fast. Results come in 15 minutes!

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
25 years
since May 3, 1999
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
15,984,362
2 share classes
Total number of shareholders
115
56 companies, 59 persons

Financials

Total operating income 2023
989,396
NOK
Annual total result 2023
-44,421,682
NOK
Total equity 2023
-902,344
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Board Member
2.15 %
indirectly
Board Member-
Board Member-
Board Member
1.74 %
directly
Board Member
2.44 %
directly 2.13 %
indirectly 0.31 %
Chairman-
Contact Person-

Top 10 individual shareholders

NameRoleShares
-
7.33 %
indirectly
-
7.33 %
indirectly
-
4.88 %
indirectly
-
4.88 %
indirectly
-
4.38 %
indirectly
-
3.91 %
indirectly
-
2.75 %
indirectly
-
2.61 %
directly
Board Member
2.44 %
directly 2.13 %
indirectly 0.31 %
-
2.35 %
indirectly
Last update: Apr 5, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
W
WAATVIKA AS
NO0010851546
2,344,571
14.67 %
G
GILBO INVEST AS
NO0010851546
1,418,652
8.88 %
B
BMT UTVIKLING AS
NO0010851546
1,237,998
7.75 %
G
GARDER INVEST AS
NO0010851546
936,324
5.86 %
J
JAHATT AS
NO0010851546
700,000
4.38 %
M
METEVA AS
NO0010851546
625,719
3.91 %
N
NORINNOVA INVEST AS
NO0010851546
467,289
2.92 %
L
LJM AS
NO0010851546
439,482
2.75 %
N
NANNIK AS
NO0010851546
412,224
2.58 %
C
CB INVEST AS
NO0010851546
375,000
2.35 %
K
KEWA INVEST AS
NO0010851546
366,765
2.29 %
V
VINSNESBAKK EIENDOM AS
NO0010851546
350,497
2.19 %
NO0010851546
349,096
2.18 %
NO0010851546
340,394
2.13 %
V
VOLDSTAD EIENDOM AS
NO0010851546
330,092
2.07 %
NO0010851553
325,000
2.03 %
W
WLH INVEST AS
NO0010851546
291,508
1.82 %
NO0010851553
277,778
1.74 %
H
HAPPY 2 AS
NO0010851546
236,498
1.48 %
NO0010851546
235,953
1.48 %
H
HEIN HOLDING AS
NO0010851546
231,397
1.45 %
V
VALERE AS
NO0010851553
222,222
1.39 %
L
LYFSTONE AS
NO0010851546
188,398
1.18 %
NO0010851546
172,500
1.08 %
NO0010851546
154,426
0.97 %
A
ARTEL AS
NO0010851546
150,000
0.94 %
N
NORINNOVA AS
NO0010851546
139,730
0.87 %
NO0010851546
125,000
0.78 %
T
TONITO AS
NO0010851546
112,724
0.71 %
NO0010851553
110,000
0.69 %
S
SÅKORNINVEST MIDT-NORGE AS
NO0010851546
108,775
0.68 %
NO0010851546
92,139
0.58 %
V
VALERE AS
NO0010851546
91,500
0.57 %
R
RIBAT AS
NO0010851546
89,547
0.56 %
H
HAPPY 2 AS
NO0010851553
88,788
0.56 %
C
CREAR AS
NO0010851546
85,194
0.53 %
S
SKAJEM HOLDING AS
NO0010851546
82,037
0.51 %
NO0010851553
81,286
0.51 %
L
LYNGEN BIOMED AS
NO0010851546
77,008
0.48 %
NO0010851546
67,453
0.42 %
T
TAASEN INVEST AS
NO0010851546
67,370
0.42 %
A
ARCATUM AS
NO0010851546
67,084
0.42 %
F
FHS HOLDING AS
NO0010851546
65,000
0.41 %
H
HUNTER HOLDING AS
NO0010851546
62,500
0.39 %
NO0010851546
59,053
0.37 %
NO0010851546
56,511
0.35 %
NO0010851546
50,000
0.31 %
G
GARDER INVEST AS
NO0010851553
50,000
0.31 %
K
KM FORVALTNING AS
NO0010851546
44,000
0.28 %
V
VIOM HOLDING AS
NO0010851546
40,833
0.26 %
T
TITUS INVEST AS
NO0010851546
40,833
0.26 %
H
HYBRID INVESTMENTS AS
NO0010851546
40,000
0.25 %
NO0010851546
37,500
0.23 %
NO0010851546
37,165
0.23 %
NO0010851546
32,589
0.2 %
NO0010851546
30,000
0.19 %
NO0010851546
30,000
0.19 %
B
BORGSØEN INVEST AS
NO0010851546
28,639
0.18 %
O
ODYSSY AS
NO0010851546
26,250
0.16 %
NO0010851553
25,000
0.16 %
NO0010851546
22,500
0.14 %
H
HANSSON INVEST AS
NO0010851546
22,500
0.14 %
N
NYTT VINDU AS
NO0010851546
22,375
0.14 %
NO0010851546
22,237
0.14 %
NO0010851546
21,868
0.14 %
I
INEIKEN AS
NO0010851546
20,853
0.13 %
NO0010851553
20,000
0.13 %
T
TOHATT AS
NO0010851546
20,000
0.13 %
A
AKULEG AS
NO0010851546
18,750
0.12 %
NO0010851546
17,382
0.11 %
NO0010851546
15,000
0.09 %
NO0010851553
15,000
0.09 %
NO0010851553
13,000
0.08 %
B
B-O CONSULTING AS
NO0010851546
12,500
0.08 %
NO0010851546
10,853
0.07 %
NO0010851546
10,271
0.06 %
NO0010851546
10,271
0.06 %
NO0010851546
10,271
0.06 %
NO0010851546
10,000
0.06 %
NO0010851553
10,000
0.06 %
B
BACK IN BLACK CAPITAL AS
NO0010851546
10,000
0.06 %
A
ANFAR INVEST AS
NO0010851546
10,000
0.06 %
NO0010851546
7,000
0.04 %
A
AKZ AS
NO0010851546
6,250
0.04 %
NO0010851546
6,000
0.04 %
NO0010851546
5,000
0.03 %
NO0010851546
4,518
0.03 %
K
KAG AS
NO0010851546
4,286
0.03 %
NO0010851546
4,000
0.03 %
NO0010851546
3,763
0.02 %
W
WSQ AS
NO0010851546
3,297
0.02 %
J
JSQ AS
NO0010851546
3,297
0.02 %
M
MSK AS
NO0010851546
3,296
0.02 %
E
ELSQ AS
NO0010851546
3,296
0.02 %
T
TEMPO PRIMO HOLDING AS
NO0010851546
3,296
0.02 %
NO0010851546
3,000
0.02 %
A
AVIDIT AS
NO0010851546
2,893
0.02 %
NO0010851546
2,706
0.02 %
NO0010851546
2,000
< 0.01 %
NO0010851546
2,000
< 0.01 %

Shares owned by the LYFSTONE AS

NameShare classNumber of sharesShare
L
LYFSTONE AS
NO0010851546
188,398
1.18 %
L
LYFSTONE INVEST AS
Ordinary shares
30,000
1.06 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
989,396
162,535,969
342,048
Annual Total Result
-44,421,682
16,769,270
-16,194,815
Total assets
1,480,334
45,692,508
22,890,581
Total liabilities
2,382,677
2,173,169
13,964,775
Total equity
-902,344
43,519,339
8,925,807

P&L

Year202320222021
Total operating income
989,396
162,535,969
342,048
Total operating costs
1,280,516
14,372,192
16,038,312
Operating result
-291,120
148,163,777
-15,696,264
Financial income/costs
-44,194,747
-129,701,780
-498,551
Profit before tax
-44,485,866
18,461,997
-16,194,815
Total tax & extraordinary income/cost
-64,184
1,692,727
0
Annual Total Result
-44,421,682
16,769,270
-16,194,815

Balance overview

Year202320222021
Total fixed assets
30,000
44,230,000
18,072,850
Total current assets
1,450,334
1,462,508
4,817,731
Total assets
1,480,334
45,692,508
22,890,581
Short term debt
754,134
480,442
2,054,241
Long term debt
1,628,543
1,692,727
11,910,534
Total liabilities
2,382,677
2,173,169
13,964,775
Contributed capital
4,200,845
31,853,258
14,028,996
Retained earnings
-5,103,189
11,666,081
-5,103,189
Total equity
-902,344
43,519,339
8,925,807
Total equity and liabilities
1,480,334
45,692,508
22,890,581

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology